Loading
Latest filing published 08 Jul 2026 for Niagen Bioscience, Inc., €5,494. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Carlos Luis Lopez in Niagen Bioscience, Inc. We count 2 filings; the first trade dates from 7 March 2025 and the latest from 30 June 2026.
Purchases make up the whole of the open-market record (1 purchase, €1,989). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant.
The newest entry dates from 8 July 2026: a share grant of €5,494, in Niagen Bioscience, Inc. The last insider purchase was made public on 10 March 2025, 587 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations